EDAP TMS SA -ADR
FOCLNASDAQTrading Snapshot
- Day Range
- $346.61 β $357.20
- 52-Week Range
- $4.00 β $6.40
- Volume
- $4.98B
- Avg Volume
- $3.89B
- Shares Outstanding
- 37.5M
- Next Earnings
- Dec 13, 2026
Fundamentals Snapshot
- Annual Revenue
- $71M
- Last Q Revenue
- $13M
- P/E Ratio
- β
- P/S Ratio
- 2.6x
- EPS (TTM)
- $-1.04
- Dividend Yield
- β
- Dilution (1yr)
- +0.2%
Why Investors Own FOCL
- βHigh-growth profile β revenue up +58.3% YoY with expanding US Equity exposure.
- βHealthy economics β 31% gross margin and 7% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
EDAP TMS SA -ADR
FOCLAbout EDAP TMS SA -ADR
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycleβfrom development and marketing to manufacturing and servicingβof medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
EDAP TMS SA -ADR tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift FOCL price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
EDAP TMS SA -ADR announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.